KEY FEATURES
| Full Name | Stromal Cell Derived Factor 1 |
|---|---|
| Synonym | CXCL12; PBSF; P-BSF; SCYB12; SDF1-A; SDF1-B; SDF1A; SDF1B; TLSF-A; TLSF-B; TPAR1; Pre-B Cell Growth-Stimulating Factor; Chemokine C-X-C-Motif Ligand 12 |
| Assay Type | Sandwich |
| Reactivity | Mouse |
| Range | 62.5-4000pg/mL |
| Sensitivity | 26.1pg/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Mouse SDF1 in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Mouse SDF1. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Mouse SDF1 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Mouse SDF1, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Mouse SDF1. You can calculate the concentration of Mouse SDF1 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Mouse SDF1 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (pg/mL) | 206.86 | 343.52 | 1874.19 | 206.03 | 334.95 | 1812.24 |
| Standard deviation | 13.36 | 16.45 | 99.52 | 10.49 | 14.2 | 60.53 |
| CV(%) | 6.46 | 4.79 | 5.31 | 5.09 | 4.24 | 3.34 |
RECOVERY
The recovery of Mouse SDF1 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 92-108 | 100 |
| EDTA plasma (n=8) | 91-103 | 97 |
| Cell culture media (n=8) | 92-106 | 98 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Mouse SDF1 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with CXCL12 ELISA Kits
| CXCR4 ELISA Kit | publications with CXCL12 and CXCR4 |
| CCR5 ELISA Kit | publications with CXCL12 and CCR5 |
| CXCR7 ELISA Kit | publications with CXCL12 and CXCR7 |
| CXCR3 ELISA Kit | publications with CXCL12 and CXCR3 |
| HIF1A ELISA Kit | publications with CXCL12 and HIF1A |
| CCR4 ELISA Kit | publications with CXCL12 and CCR4 |
| STAT3 ELISA Kit | publications with CXCL12 and STAT3 |
| JAK2 ELISA Kit | publications with CXCL12 and JAK2 |
| VAV1 ELISA Kit | publications with CXCL12 and VAV1 |
| SDC4 ELISA Kit | publications with CXCL12 and SDC4 |
Pathways associated with CXCL12 ELISA Kit
| Axon Guidance Pathway | Axon Guidance Pathway |
| CXCR4-mediated Signaling Events Pathway | CXCR4-mediated Signaling Events Pathway |
| Chemokine Receptors Bind Chemokines Pathway | Chemokine Receptors Bind Chemokines Pathway |
| Chemokine Signaling Pathway | Chemokine Signaling Pathway |
| Class A/1 (Rhodopsin-like Receptors) Pathway | Class A/1 (Rhodopsin-like Receptors) Pathway |
| Cytokine-cytokine Receptor Interaction Pathway | Cytokine-cytokine Receptor Interaction Pathway |
| G Alpha (i) Signalling Events Pathway | G Alpha (i) Signalling Events Pathway |
Diseases associated with CXCL12 ELISA Kit
| Neoplasms | publications with CXCL12 and Neoplasms |
| Cardiovascular Diseases | publications with CXCL12 and Cardiovascular Diseases |
| Inflammation | publications with CXCL12 and Inflammation |
| Neoplasm Metastasis | publications with CXCL12 and Neoplasm Metastasis |
| HIV Infections | publications with CXCL12 and HIV Infections |
| Heart Diseases | publications with CXCL12 and Heart Diseases |
| Breast Neoplasms | publications with CXCL12 and Breast Neoplasms |
| Ischemia | publications with CXCL12 and Ischemia |
| Neoplasm Invasiveness | publications with CXCL12 and Neoplasm Invasiveness |
| Necrosis | publications with CXCL12 and Necrosis |
Organs/Tissues associated with CXCL12 ELISA Kit
| Bone | publications with CXCL12 and Bone |
| Bone Marrow | publications with CXCL12 and Bone Marrow |
| Vascular | publications with CXCL12 and Vascular |
| Brain | publications with CXCL12 and Brain |
| Muscle | publications with CXCL12 and Muscle |
| Lung | publications with CXCL12 and Lung |
| Heart | publications with CXCL12 and Heart |
| Liver | publications with CXCL12 and Liver |
| Embryonic Tissue | publications with CXCL12 and Embryonic Tissue |
| Nerve | publications with CXCL12 and Nerve |